Aquestive Therapeutics AQST
NASDAQ AQST
$4.63 -0.04 (-0.86%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Operating Expenses (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) recorded Operating Expenses of $22.04 million in Q2 2026, up 3.1% from $21.37 million a year earlier and up 18.2% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Operating Expenses (2017 - 2026) Analysis & Trends

On a TTM basis, Aquestive Therapeutics' Operating Expenses came in at $106.83 million as of Jun 30, 2026, up 10.4% year-over-year; for FY2025, it was $115.6 million, up 30.9% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $88.33 million in FY2024 (+34.5%), $65.69 million in FY2023 (-26.8%), $89.75 million in FY2022 (+5.0%) and $85.51 million in FY2021 (-3.6%).
  • Quarterly Operating Expenses has ranged from $15.38 million in Q3 2023 to $41.85 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in seven of the last eight quarters, with growth averaging 22.0%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 64.5% in Q4 2025, against a decline of 33.6% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $18.65 million (Q1 2026), $41.85 million (Q4 2025) and $24.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Aquestive Therapeutics 586.14 Mn 126.68 Mn 9.80 Mn 22.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.04 Mn
Mar 31, 2026 18.65 Mn
Dec 31, 2025 41.85 Mn
Sep 30, 2025 24.29 Mn
Jun 30, 2025 21.37 Mn
Mar 31, 2025 28.09 Mn
Dec 31, 2024 25.45 Mn
Sep 30, 2024 21.83 Mn
Jun 30, 2024 20.04 Mn
Mar 31, 2024 21.01 Mn
Dec 31, 2023 17.12 Mn
Sep 30, 2023 15.38 Mn
Jun 30, 2023 17.45 Mn
Mar 31, 2023 15.74 Mn
Dec 31, 2022 21.40 Mn
Sep 30, 2022 20.32 Mn
Jun 30, 2022 26.03 Mn
Mar 31, 2022 22.01 Mn
Dec 31, 2021 22.75 Mn
Sep 30, 2021 21.26 Mn
API Access

Aquestive Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEY